Common use of Development Updates Clause in Contracts

Development Updates. Upon the request of ImmunoGen, CytomX shall provide ImmunoGen with brief written reports, which ImmunoGen may request no more frequently than once per Calendar Year until satisfaction of CytomX’s obligations under Section 2.2.1 hereof, that shall summarize CytomX’s efforts to Develop the Licensed Products in the Field in the Territory in sufficient detail to establish that CytomX is using Commercially Reasonable Efforts to Develop the Licensed Product, identify the applications for Regulatory Approval that CytomX or its Affiliates or Sublicensees have filed, sought or attempted to obtain in the prior twelve (12)-month period, and any they reasonably expect to file, seek or attempt to obtain in the following twelve (12)-month period. The Parties agree that the minutes of the JDC meetings may serve as reports hereunder, to the extent such minutes adequately address the above subject matter.

Appears in 2 contracts

Sources: License Agreement (CytomX Therapeutics, Inc.), Research Collaboration Agreement (CytomX Therapeutics, Inc.)

Development Updates. Upon the request of ImmunoGenCytomX, CytomX ImmunoGen shall provide ImmunoGen CytomX with brief written reports, which ImmunoGen CytomX may request no more frequently than once per Calendar Year until satisfaction of CytomXImmunoGen’s obligations under Section 2.2.1 hereof, that shall summarize CytomXImmunoGen’s efforts to Develop the Licensed Products in the Field in the Territory in sufficient detail to establish that CytomX ImmunoGen is using Commercially Reasonable Efforts to Develop the Licensed Product, identify the applications for Regulatory Approval that CytomX ImmunoGen or its Affiliates or Sublicensees have filed, sought or attempted to obtain in the prior twelve (12)-month period, and any they reasonably expect to file, seek or attempt to obtain in the following twelve (12)-month period. The Parties agree that the minutes of the JDC meetings may serve as reports hereunder, to the extent such minutes adequately address the above subject matter.

Appears in 1 contract

Sources: Research Collaboration Agreement (CytomX Therapeutics, Inc.)